Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Peter Reimer, MD, Thomas Ruediger, MD, Florian Weissinger, MD, Hans Konrad Mueller-Hermelink, Andreas Engert, Hermann Einsele, Martin Wilhelm

Blood (2006) 108 (11): 5431.

https://doi.org/10.1182/blood.V108.11.5431.5431

Published: 2006

Journal Articles

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

Lucia Nogova, MD, Thorsten Reineke, Corinne Brillant, Thomas Ruediger, Prof, Hans K. Mueller-Hermelink, Prof., Henning Bredenfeld, MD, Andreas Josting, MD, Rolf P. Mueller, Prof., Volker Diehl, Prof., Andreas Engert, Prof.

Blood (2006) 108 (11): 97.

https://doi.org/10.1182/blood.V108.11.97.97

Published: 2006

Journal Articles

International T-Cell Lymphoma Classification Project: Angioimmunoblastic T-Cell Lymphoma.

Thomas Ruediger, MD, Bertrand Coiffier, MD, Dennis D. Weisenburger, MD, Massimo Federico, MD

Blood (2006) 108 (11): 2052.

https://doi.org/10.1182/blood.V108.11.2052.2052

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Peter Reimer, MD, Thomas Ruediger, MD, Tobias Schertlin, MD, Eva Geissinger, MD, Florian Weissinger, MD, Hermann Einsele, Hans Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2005) 106 (11): 2074.

https://doi.org/10.1182/blood.V106.11.2074.2074

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.

Peter Reimer, MD, Thomas Ruediger, MD, Tobias Schertlin, Eva Geissinger, MD, Florian Weissinger, MD, Hans Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2004) 104 (11): 904.

https://doi.org/10.1182/blood.V104.11.904.904

Published: 2004

Journal Articles

γδ T cells for immune therapy of patients with lymphoid malignancies

Martin Wilhelm, Volker Kunzmann, Susanne Eckstein, Peter Reimer, Florian Weissinger, Thomas Ruediger, Hans-Peter Tony

Blood (2003) 102 (1): 200–206.

https://doi.org/10.1182/blood-2002-12-3665

Published: 2003

Journal Articles

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

Volker Kunzmann, Thomas Ruediger, Michael Hallek, Hans-Konrad Mueller-Hermelink, Martin Wilhelm

Blood (2001) 98 (6): 1991–1992.

https://doi.org/10.1182/blood.V98.6.1991

Published: 2001

NARROW

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

International T-Cell Lymphoma Classification Project: Angioimmunoblastic T-Cell Lymphoma.

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.

γδ T cells for immune therapy of patients with lymphoid malignancies

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

Email alerts

ASH Publications

American Society of Hematology

Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

International T-Cell Lymphoma Classification Project: Angioimmunoblastic T-Cell Lymphoma.

Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.

Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.

γδ T cells for immune therapy of patients with lymphoid malignancies

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only